Analysts Expect Nutanix Inc (NASDAQ:NTNX) to Post -$0.75 Earnings Per Share

Share on StockTwits

Wall Street analysts expect Nutanix Inc (NASDAQ:NTNX) to post ($0.75) earnings per share for the current fiscal quarter, according to Zacks. Seven analysts have made estimates for Nutanix’s earnings, with the lowest EPS estimate coming in at ($0.78) and the highest estimate coming in at ($0.71). Nutanix reported earnings of ($0.13) per share during the same quarter last year, which would indicate a negative year over year growth rate of 476.9%. The business is expected to issue its next earnings report on Tuesday, November 26th.

According to Zacks, analysts expect that Nutanix will report full year earnings of ($2.95) per share for the current financial year, with EPS estimates ranging from ($3.11) to ($2.82). For the next fiscal year, analysts expect that the firm will report earnings of ($2.43) per share, with EPS estimates ranging from ($2.88) to ($2.10). Zacks’ earnings per share averages are an average based on a survey of research firms that that provide coverage for Nutanix.

Nutanix (NASDAQ:NTNX) last announced its quarterly earnings data on Wednesday, August 28th. The technology company reported ($0.96) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($1.05) by $0.09. Nutanix had a negative net margin of 50.25% and a negative return on equity of 172.43%. The business had revenue of $299.90 million during the quarter, compared to analyst estimates of $293.49 million. During the same period last year, the firm posted ($0.11) EPS. The company’s revenue was down 1.3% on a year-over-year basis.

A number of brokerages have issued reports on NTNX. Piper Jaffray Companies cut their price objective on shares of Nutanix from $28.00 to $25.00 and set a “neutral” rating for the company in a report on Tuesday, August 27th. UBS Group raised shares of Nutanix to a “positive” rating and raised their target price for the company from $23.00 to $45.00 in a report on Monday, September 9th. William Blair reissued a “buy” rating on shares of Nutanix in a report on Thursday, August 29th. Susquehanna Bancshares raised shares of Nutanix from a “negative” rating to a “positive” rating and raised their target price for the company from $23.00 to $45.00 in a report on Monday, September 9th. Finally, Royal Bank of Canada cut their target price on shares of Nutanix from $39.00 to $32.00 and set an “outperform” rating for the company in a report on Wednesday, August 28th. Nine equities research analysts have rated the stock with a hold rating, thirteen have given a buy rating and one has issued a strong buy rating to the company. Nutanix has an average rating of “Buy” and an average target price of $37.31.

In related news, CEO Dheeraj Pandey sold 9,489 shares of the firm’s stock in a transaction on Monday, September 16th. The stock was sold at an average price of $26.71, for a total value of $253,451.19. Following the completion of the sale, the chief executive officer now directly owns 250,975 shares in the company, valued at $6,703,542.25. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, CFO Duston Williams sold 19,610 shares of the firm’s stock in a transaction on Monday, September 16th. The stock was sold at an average price of $26.71, for a total value of $523,783.10. Following the completion of the sale, the chief financial officer now owns 218,596 shares of the company’s stock, valued at $5,838,699.16. The disclosure for this sale can be found here. Over the last three months, insiders sold 34,951 shares of company stock valued at $933,541. 14.57% of the stock is currently owned by insiders.

A number of institutional investors and hedge funds have recently modified their holdings of the stock. Generation Investment Management LLP bought a new stake in Nutanix in the second quarter worth $374,127,000. Vanguard Group Inc. lifted its position in Nutanix by 1.2% in the second quarter. Vanguard Group Inc. now owns 11,956,664 shares of the technology company’s stock worth $310,155,000 after buying an additional 136,311 shares during the last quarter. Eminence Capital LP bought a new stake in shares of Nutanix during the second quarter worth $99,453,000. First Trust Advisors LP lifted its position in shares of Nutanix by 167.4% during the second quarter. First Trust Advisors LP now owns 1,952,096 shares of the technology company’s stock worth $50,637,000 after purchasing an additional 1,221,956 shares during the last quarter. Finally, ARK Investment Management LLC lifted its position in shares of Nutanix by 651.0% during the second quarter. ARK Investment Management LLC now owns 1,412,100 shares of the technology company’s stock worth $36,630,000 after purchasing an additional 1,224,081 shares during the last quarter. Institutional investors own 63.92% of the company’s stock.

Shares of NTNX opened at $26.19 on Thursday. The company has a debt-to-equity ratio of 2.46, a current ratio of 2.13 and a quick ratio of 2.13. Nutanix has a 1 year low of $17.74 and a 1 year high of $54.68. The company has a 50 day simple moving average of $25.13 and a two-hundred day simple moving average of $28.97. The firm has a market cap of $4.83 billion, a P/E ratio of -8.24 and a beta of 1.30.

Nutanix Company Profile

Nutanix, Inc, together with its subsidiaries, develops and provides an enterprise cloud platform in North America, Europe, the Asia Pacific, the Middle East, Latin America, and Africa. Its solution addresses a range of workloads, including enterprise applications, databases, virtual desktop infrastructure, unified communications, and big data analytics.

Featured Story: Percentage Decliners

Get a free copy of the Zacks research report on Nutanix (NTNX)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Nutanix (NASDAQ:NTNX)

Receive News & Ratings for Nutanix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutanix and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Benjamin F. Edwards & Company Inc. Buys 2,216 Shares of Cardinal Health Inc
Benjamin F. Edwards & Company Inc. Buys 2,216 Shares of Cardinal Health Inc
Benjamin F. Edwards & Company Inc. Raises Stake in Marriott International Inc
Benjamin F. Edwards & Company Inc. Raises Stake in Marriott International Inc
Alps Advisors Inc. Has $361,000 Stake in Stryker Co.
Alps Advisors Inc. Has $361,000 Stake in Stryker Co.
Benjamin F. Edwards & Company Inc. Sells 436 Shares of Brown & Brown, Inc.
Benjamin F. Edwards & Company Inc. Sells 436 Shares of Brown & Brown, Inc.
Eagle Asset Management Inc. Grows Holdings in Netflix, Inc.
Eagle Asset Management Inc. Grows Holdings in Netflix, Inc.
Alps Advisors Inc. Purchases New Stake in CVS Health Corp
Alps Advisors Inc. Purchases New Stake in CVS Health Corp


© 2006-2019 Ticker Report